Stock Taper 
SEER
$2.03
▲ UP 0.50% (0.01)
KEY STATISTICS
Market Cap$111.61 M
52w High$2.41
52w Low$1.55
Dividend Yield—
Frequency—
P/E-1.64
Volume117.10K
Shares Out.54.98M
COMPANY
LEADERSHIP
CHIEF EXECUTIVE
Omid C. Farokhzad
COMPENSATION 2026
Salary$619,208
Stock Awards$937,452
Incentive Plan Pay$397,174
All Other Comp.$173,192
Total$3,549,950
ABOUT
SECTOR
Healthcare
WENT PUBLIC
December 4, 2020
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
124
PRICE TARGET
Target High$4.00
Target Low$4.00
Target Median$4.00
Target Consensus$4.00
UPCOMING EARNINGS
DateNov 5, 2026
DayThursday
Rev. Est.$4.15M
NOV
5
THU
PRICE
$2.03 ▲ UP 0.50% (+$0.01)About Seer, Inc.
https://seer.bio ↗Seer, Inc. develops the Proteograph Product Suite to enable proteomic research for academia and biotech firms, collaborating with Discovery Life Sciences and Salk Institute, and is based in Redwood City, CA.
INDUSTRY
Biotechnology
A PRODUCT SEER, INC. IS KNOWN FOR
Proteograph Product Suite with Proteograph ONE Assay and SP200 Automation Instrument
Seer's Proteograph Product Suite, launched in May 2025, offers high-throughput, scalable proteomic analysis with the Proteograph ONE Assay and SP200 Automation Instrument, enabling biomarker discovery and personalized medicine insights.
Revenue by Products
| Icon | PRODUCT | Q1-2023 | Q2-2023 | Q3-2023 | Q4-2023 |
|---|---|---|---|---|---|
 | Product | $2.34M | — | — | — |
 | Related Party | $1.31M | — | — | — |
 | Grant | — | $500K | $200K ▼ | $400K ▲ |
 | Grant and Other | $335K | — | — | — |
 | Service | $69K | — | — | — |
ETFS HOLDING THIS STOCK
ETFS HOLDING
22
LISTED HERE
6
RANKED BY POSITION SIZE
INSTITUTIONAL OWNERSHIP
SHARES OWNED
50.87%
HOLDERS
82
TOP 12 OF 82 · RANKED BY POSITION SIZE
Sb Global Advisers Ltd
Softbank Group Corp.
Siren, L.L.C.
Blackrock Inc.
Vanguard Group Inc
Acadian Asset Management LLC
Blackrock, Inc.
Tang Capital Management LLC
Renaissance Technologies LLC
Nano Cap New Millennium Growth Fund L P
Aju Ib Investment Co., Ltd.
Bridgeway Capital Management, LLC
RATINGS SNAPSHOT
Overall rating: C+
Discounted Cash Flow1
Return On Equity1
Return On Assets1
Debt To Equity3
Price To Earnings1
Price To Book5
Overall Score2
INSIDER TRADES
★
OFFICER: PRESIDENT & CFO
Horn David R.
Sale · 7.3K shares
2026-08-18
★
DIRECTOR
Ro Isaac
Purchase · 12.4K shares
2026-07-28
★
DIRECTOR
Roelofs Nicolas H PHD
Purchase · 16.5K shares
2026-07-28
★
DIRECTOR
Roelofs Nicolas H PHD
Purchase · 25.0K shares
2026-07-28
SECTORS PEERS
| PEER | PRICE | |
|---|---|---|
 KYMR | $119.80 | COMPARE |
 NRIX | $26.72 | COMPARE |
 PHVS | $36.27 | COMPARE |
 MLYS | $25.65 | COMPARE |
 ORIC | $14.20 | COMPARE |
 CGEM | $21.68 | COMPARE |
 GLUE | $14.30 | COMPARE |
 SANA | $3.91 | COMPARE |